Found 346 clinical trials
Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI (EPIDAURUS)
The selection of the optimal antithrombotic therapy in patients with nonvalvular atrial fibrillation (AF) and acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) is
- 0 views
- 01 May, 2022
- 2 locations
Colchicine and Spironolactone in Patients With MI / SYNERGY Stent Registry (CLEAR SYNERGY)
The CLEAR SYNERGY trial will study the long term effects of treatments following PCI to treat myocardial infarction. These treatments address both the culprit artery (PCI with SYNERGY stent) as
- 23 views
- 04 Oct, 2022
- 1 location
Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI
percutaneous coronary intervention (PCI).
- 0 views
- 24 Jan, 2021
- 1 location
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
More than 25% of patients referred for diagnostic coronary angiography and percutaneous coronary intervention (PCI) due to acute coronary syndrome (ACS) suffer from non-valvular atrial
- 0 views
- 12 Nov, 2021
- 1 location
Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion
undergoing elective percutaneous coronary intervention with drug eluting stents for complex coronary lesions.
- 0 views
- 19 Nov, 2021
- 1 location
"MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome
coronary revascularization as a result of the first episode of the acute coronary syndrome (ACS).
- 0 views
- 21 Apr, 2022
- 1 location
The Randomized OPTIMAL-ACT Trial
Despite the widespread adoption of recommended anticoagulation intensity ranges during percutaneous coronary intervention (PCI), there are limited randomized clinical trials testing specific
- 0 views
- 24 Mar, 2022
- 1 location
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial
Previous randomized clinical trials have deomonstrated the efficacy and safety of short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), however, the single
- 0 views
- 22 Oct, 2022
- 1 location
SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3 (SMART-CHOICE3)
after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) in patients being treated with dual antiplatelet therapy (DAPT) at high risk for recurrent ischemic events.
- 0 views
- 14 Mar, 2022
- 1 location
Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients
coronary intervention, as well as observed the incidence of CIN.
- 0 views
- 24 Mar, 2022
- 1 location